Liu Yuxi
Datos Biográficos
| ID | 7291069 |
|---|---|
| NOMBRE | Liu Yuxi |
| NOMBRES | Liu |
| APELLIDO | Yuxi |
| FIRMA | YUXI L |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2025 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
A TCM formula assists temozolomide in anti-melanoma therapy by suppressing the STAT3 signaling pathway
Synergistic anti-melanoma effects of SLE/TMZ have been observed in animal and cellular models. One of the mechanisms of SLE/TMZ that underlies its anti-melanoma actions is inhibition of the STAT3 pathway. This work offers pre-clinical pharmacological backing for the advancement of SLE as a therapeutic agent to be used in conjunction with TMZ for the treatment of melanoma
Sin obras prominentes en esta página.
A TCM formula assists temozolomide in anti-melanoma therapy by suppressing the STAT3 signaling pathway
Synergistic anti-melanoma effects of SLE/TMZ have been observed in animal and cellular models. One of the mechanisms of SLE/TMZ that underlies its anti-melanoma actions is inhibition of the STAT3 pathway. This work offers pre-clinical pharmacological backing for the advancement of SLE as a therapeutic agent to be used in conjunction with TMZ for the treatment of melanoma
Biology (1 obras) · Cancer Mechanisms and Therapy (1 obras) · Cancer Research (1 obras) · Chemotherapy (1 obras) · Cytokine Signaling Pathways and Interactions (1 obras) · Internal Medicine (1 obras) · Medicine (1 obras) · Melanoma (1 obras) · Melanoma and MAPK Pathways (1 obras) · Oncology (1 obras)